Somerset Trust’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.78M | Sell |
48,273
-250
| -0.5% | -$20.2K | 1.07% | 32 |
|
|
2026
Q1 | $4.2M | Sell |
48,523
-1,014
| -2% | -$97.1K | 1.29% | 26 |
|
|
2025
Q4 | $4.76M | Buy |
49,537
+288
| +0.6% | +$28K | 1.46% | 25 |
|
|
2025
Q3 | $4.69M | Buy |
49,249
+422
| +0.9% | +$38.8K | 1.45% | 26 |
|
|
2025
Q2 | $4.26M | Buy |
48,827
+68
| +0.1% | +$5.77K | 1.39% | 27 |
|
|
2025
Q1 | $4.38M | Buy |
48,759
+3,394
| +7% | +$304K | 1.56% | 23 |
|
|
2024
Q4 | $3.62M | Sell |
45,365
-477
| -1% | -$41.3K | 1.36% | 28 |
|
|
2024
Q3 | $4.13M | Sell |
45,842
-2,042
| -4% | -$172K | 1.54% | 23 |
|
|
2024
Q2 | $3.77M | Buy |
47,884
+99
| +0.2% | +$8.12K | 1.55% | 23 |
|
|
2024
Q1 | $4.16M | Buy |
47,785
+917
| +2% | +$78.3K | 1.7% | 20 |
|
|
2023
Q4 | $3.86M | Sell |
46,868
-957
| -2% | -$72.9K | 1.69% | 19 |
|
|
2023
Q3 | $3.75M | Sell |
47,825
-630
| -1% | -$52.7K | 1.71% | 20 |
|
|
2023
Q2 | $4.27M | Sell |
48,455
-1,924
| -4% | -$166K | 1.84% | 16 |
|
|
2023
Q1 | $4.06M | Sell |
50,379
-1,759
| -3% | -$143K | 1.76% | 16 |
|
|
2022
Q4 | $4.05M | Sell |
52,138
-1,856
| -3% | -$150K | 1.7% | 18 |
|
|
2022
Q3 | $4.36M | Buy |
53,994
+258
| +0.5% | +$23.2K | 2.03% | 11 |
|
|
2022
Q2 | $4.82M | Buy |
53,736
+322
| +0.6% | +$32.6K | 2.11% | 7 |
|
|
2022
Q1 | $5.93M | Sell |
53,414
-624
| -1% | -$65.9K | 2.29% | 7 |
|
|
2021
Q4 | $5.59M | Buy |
54,038
+1,023
| +2% | +$118K | 2.04% | 10 |
|
|
2021
Q3 | $6.64M | Sell |
53,015
-350
| -0.7% | -$45.3K | 2.71% | 6 |
|
|
2021
Q2 | $6.62M | Sell |
53,365
-92
| -0.2% | -$11.6K | 2.7% | 5 |
|
|
2021
Q1 | $6.32M | Buy |
53,457
+286
| +0.5% | +$33.5K | 2.72% | 6 |
|
|
2020
Q4 | $6.23M | Sell |
53,171
-593
| -1% | -$65.3K | 2.83% | 5 |
|
|
2020
Q3 | $5.59M | Buy |
53,764
+743
| +1% | +$74.6K | 2.81% | 6 |
|
|
2020
Q2 | $4.86M | Buy |
53,021
+1,074
| +2% | +$103K | 2.59% | 8 |
|
|
2020
Q1 | $4.68M | Sell |
51,947
-861
| -2% | -$91.6K | 3.07% | 4 |
|
|
2019
Q4 | $5.99M | Buy |
52,808
+113
| +0.2% | +$12.4K | 2.96% | 3 |
|
|
2019
Q3 | $5.72M | Sell |
52,695
-1,704
| -3% | -$178K | 3.02% | 2 |
|
|
2019
Q2 | $5.3M | Buy |
54,399
+170
| +0.3% | +$15.5K | 2.73% | 3 |
|
|
2019
Q1 | $4.94M | Buy |
54,229
+187
| +0.3% | +$16.7K | 2.6% | 4 |
|
|
2018
Q4 | $4.92M | Buy |
54,042
+331
| +0.6% | +$30.9K | 2.86% | 3 |
|
|
2018
Q3 | $5.28M | Buy |
53,711
+565
| +1% | +$52.2K | 2.61% | 4 |
|
|
2018
Q2 | $4.55M | Sell |
53,146
-1,753
| -3% | -$146K | 2.44% | 5 |
|
|
2018
Q1 | $4.4M | Sell |
54,899
-151
| -0.3% | -$12.5K | 2.28% | 8 |
|
|
2017
Q4 | $4.45M | Sell |
55,050
-2,492
| -4% | -$200K | 2.22% | 8 |
|
|
2017
Q3 | $4.47M | Sell |
57,542
-1,981
| -3% | -$164K | 2.37% | 3 |
|
|
2017
Q2 | $5.28M | Buy |
59,523
+2,201
| +4% | +$186K | 2.88% | 2 |
|
|
2017
Q1 | $4.62M | Buy |
57,322
+14,001
| +32% | +$1.09M | 2.59% | 3 |
|
|
2016
Q4 | $3.08M | Sell |
43,321
-2,610
| -6% | -$205K | 1.83% | 9 |
|
|
2016
Q3 | $3.97M | Buy |
45,931
+400
| +0.9% | +$34.9K | 2.36% | 4 |
|
|
2016
Q2 | $3.95M | Buy |
45,531
+5,845
| +15% | +$473K | 2.44% | 3 |
|
|
2016
Q1 | $2.98M | Buy |
39,686
+291
| +0.7% | +$21.9K | 1.97% | 4 |
|
|
2015
Q4 | $3.03M | Buy |
39,395
+474
| +1% | +$35.7K | 1.99% | 5 |
|
|
2015
Q3 | $2.61M | Buy |
38,921
+12,627
| +48% | +$930K | 1.83% | 6 |
|
|
2015
Q2 | $1.95M | Buy |
26,294
+10,076
| +62% | +$770K | 1.28% | 20 |
|
|
2015
Q1 | $1.26M | Buy |
16,218
+1,179
| +8% | +$89.4K | 0.83% | 42 |
|
|
2014
Q4 | $1.09M | Buy |
15,039
+409
| +3% | +$28.4K | 0.72% | 45 |
|
|
2014
Q3 | $907K | Buy |
14,630
+380
| +3% | +$24.2K | 0.63% | 55 |
|
|
2014
Q2 | $908K | Buy |
14,250
+1,060
| +8% | +$64.4K | 0.64% | 51 |
|
|
2014
Q1 | $812K | Buy |
13,190
+630
| +5% | +$36.7K | 0.62% | 52 |
|
|
2013
Q4 | $721K | Buy |
+12,560
| New | +$712K | 0.55% | 56 |
|
Other funds holding MDT
LMFP
FWIA
DC
GI
MAA
CGH
CNB
Somerset Trust's MDT Position: Q2 2026 in Review
Somerset Trust reduced its Medtronic (MDT) stake by 0.52% in Q2 2026, selling an estimated $20.2K and leaving 48,273 shares worth $3.78M. The position accounts for 1.07% of the portfolio, ranked #32.
Somerset Trust first reported a position in MDT in Q4 2013 and has held it in 51 quarters since. The position peaked at $6.64M in Q3 2021. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Somerset Trust held 48,273 shares of Medtronic worth $3.78M as of Q2 2026.
- Somerset Trust sold 250 Medtronic shares in Q2 2026, an estimated $20.2K.
- Medtronic made up 1.07% of Somerset Trust's portfolio in Q2 2026, its #32 holding.
- Somerset Trust first reported a position in Medtronic in Q4 2013 and has held it in 51 quarters since.
- Somerset Trust's Medtronic position peaked at $6.64M in Q3 2021.
- 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Somerset Trust's 13F filing for Q2 2026, filed 6 Jul 2026.